The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.

Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study ...

A research team comprising several researchers within the University of Kentucky's Sanders-Brown Center on Aging has ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

The five big factors increasing the risk for cognitive decline, dementia or both: diabetes, midlife hypertension or high ...

Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

A study of individuals with mild cognitive impairment and Alzheimer’s disease in France found that participants who consumed ...